Table 2. Individual Participation in trachoma MDA (N = 1,791).

Indicator	N	%*	95% CI
Gender of respondents
Male	858	47.7	45.7–49.6
Female	924	52.3	50.4–54.3
Missing data	9
Age
<5 years	266	14.6	12.8–16.4
5–9 years	297	15.9	13.2–18.5
10–19 years	421	23.9	22.1–25.8
20–29 years	295	17.1	14.6–19.7
30–39 years	213	11.4	10.1–12.8
40–49 years	135	7.6	6.8–8.4
50–59 years	85	4.8	3.6–5.9
60–69 years	39	2.5	1.7–3.3
70 years and older	40	2.2	1.6–2.8
Participation in trachoma MDA
No	629	39.6	26.2–53.1
Yes	1072	60.4	46.9–73.8
Missing data	90
Drug type (n = 1072)
Azithromycin	997	93.4	87.0–99.9
Tetracycline Eye Ointment	22	1.8	0.6–2.9
Both	53	4.8	0.0–11.1
Verification of treatment among respondents
Record matched CDD register	658	56.6	31.2–82.1
Record did not match CDD register	24	2.4	0.0–6.5
No record of participant	546	41.0	16.0–66.0
Missing Data	562
Reason for not participating (n = 629)
Refused	25	3.5	0.6–6.5
Missed	220	33.7	15.2–52.3
Not distributed	373	62.7	42.8–82.6
Missing data	11
Ever taken drugs for other MDA1 (n = 492)
No	187	45.9	26.9–64.9
Yes	232	54.1	35.1–73.1
Missing data	73

^*Frequencies are weighted by cluster.

¹Among children 6–15 years of age.